UroMems is a biotechnology company based out of LES REFLETS DU DRAC 32 RUE GUSTAVE EIFFEL, GRENOBLE, France.
Location: France
Employees: 11-50
Total raised: $151.85M
Founded date: 2011
Investors 4
| Date | Name | Website |
| - | b2venture | b2venture.... |
| 10.07.2026 | Credit Mut... | creditmutu... |
| - | Wellington... | wellington... |
| 23.08.2022 | CITA Inves... | cita-inves... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 14.05.2026 | - | $60M | Ajax Healt... |
| 26.06.2024 | Series C | $47M | - |
| 06.04.2021 | Series B | $27.28M | - |
| 20.05.2020 | Series B | $17.57M | - |
Mentions in press and media 11
| Date | Title | Description |
| 14.05.2026 | UroMems Raises $60M in Funding | UroMems, a Grenoble, France-based developer of implantable mechatronics technology for stress urinary incontinence (SUI), raised a $60m strategic funding round. The entire financing round was backed by the U.S.-based private equity firm Aja... |
| 14.05.2026 | UroMems Raises $60M for Smart Urology Implant Trials | UroMems, a worldwide leader in medical technology and mechatronic solutions for urology, has secured $60 million in a strategic round of funding. UroMems has raised its biggest funding ever to fast-track regulatory and clinical development ... |
| 14.05.2026 | UroMems: $60 Million Raised For Smart Implant Treating Stress Urinary Incontinence | UroMems announced a $60 million strategic investment from Ajax Health to continue funding pivotal clinical trials and commercial launch preparation for the UroActive System, the company’s smart automated implant designed to treat stress uri... |
| 26.06.2024 | UroMems Raises $47M in Series C Financing | UroMems, a Grenoble, France- and Minneapolis, MN-based-based company developing implantable mechatronics technology, raised $47M in Series C funding. The round was led by Crédit Mutuel Innovation and joined by the European Innovation Counci... |
| 08.04.2021 | French medical device manufacturer UroMems completes €23M in Series B funding | (Photo by Thanakorn.P/ Shutterstock) |
| 06.04.2021 | UroMems Completes €23 Million Series B Financing | UroMems, announced that it has raised an additional €7 million in a second tranche of its previously announced Series B financing round completed in May 2020. |
| 22.05.2020 | France's UroMems scores €16M Series B | Medical device startup UroMems has raised €16 million in a round led by Hil-Invent. The company is developing an electronic artificial urinary sphincter to treat stress incontinence. The capital will be used to fund clinical trials. Additio... |
| 20.05.2020 | French medtech company UroMems raises €16 million Series B | UroMems, French developer of medical devices that help with urinary incontinence, has secured €16 million in a Series B round, a combination of equity and debt, led by Hil-Invent with co-investor Financière Arbevel. The Grenoble-based compa... |
| 20.05.2020 | UroMems Raises €16M in Funding | UroMems, a Grenoble, France-based developer and manufacturer of the electronic artificial urinary sphincter (eAUS), raised €16m in a combination of equity and debt financing. The round was led by Hil-Invent GmbH, with co-investor Financière... |
| - | UroMems | “UroMems ambition is to offer to the patients suffering from severe urinary incontinence a simple and efficient innovative solution. In a particularly demanding economic and regulatory context, the company’s ambition is to improve current s... |
Show more